WebJan 17, 2024 · The objectives of this trial are to assess the safety, performance, and effectiveness of the Edwards APTURE transcatheter shunt system when used for the treatment of patients with heart failure with preserved (HFpEF) or mildly reduced (HFmrEF) ejection fraction (LVEF >40%) WebJul 31, 2024 · Get email updates. Sign up to get the latest information about your choice of CMS topics. You can decide how often to receive updates.
G180033-1-NCT03523416 CMS
WebThe proprietary EZ Glide dispersion tip aortic cannulae feature an innovative tip disperses flow in a gentle conical spray pattern – results in lowered exit force and line pressure. … WebThe early feasibility study of the Edwards Transcatheter Atrial Shunt System is a multi-center, prospective, early feasibility study to evaluate initial clinical safety, device … forks tribal land
Device therapy with interatrial shunt devices for heart failure with ...
WebApr 12, 2024 · The early feasibility study of the Edwards Transcatheter Atrial Shunt System is a multi-center, prospective, early feasibility study to evaluate initial clinical … WebJul 25, 2024 · The Edward Transcatheter Atrial Shunt System. The shunt system is a nitinol implant and is shown in the deployed state with 2 left atrial (LA) arms (proximal and distal) and 2 coronary sinus (CS) arms (proximal and distal) surrounding a central 7-mm shunting lumen (black arrow denotes luminal diameter) as seen in the (A) long axis, (B) … WebOct 9, 2024 · The InterAtrial Shunt Device is the world’s first transcatheter device to treat heart failure with preserved (HFpEF) or mid-range ejection fraction (HFmrEF). After creating a small opening in the atrial septum, the IASD implant is deployed, forming a passage between the left and right atria that enables the left atrium to decompress at rest ... forks t shirts